Universitätsklinikum Münster

Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer (2025) Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, et al. Journal article Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults (2025) Breidenbach M, Bader P, Attarbaschi A, Rossig C, Meisel R, Metzler M, Subklewe M, et al. Journal article Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg. (2025) Kött J, Zell T, Zimmermann N, Rünger A, Smit DJ, Abeck F, Geidel G, et al. Journal article Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. (2025) Unglaub JM, Schlenk RF, Middeke JM, Krause S, Kraus S, Einsele H, Kramer M, et al. Journal article The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (2025) Roohani S, Handtke J, Hummedah K, Albertsmeier M, Andreou D, Apostolidis L, Augustin M, et al. Journal article Integrating the Patient Perspective into Healthcare and Real-World Evidence: The Multi-site, Cross-Disease, Patient-Centered Outcomes Research Project in the Medical Informatics Initiative (PCOR-MII) (2025) Rogge AA, Mukowski-Kickhöfel R, Boeker M, Budde K, Debertshäuser T, Dugas M, Erim Y, et al. Journal article Long-term cultivation of retinal pigment epithelium cells on nanofiber scaffolds (2025) Zimmermann JA, Irlenbusch L, Hansen U, Himmler M, Zeng C, Eter N, Fuchsluger T, Heiduschka P Journal article Urinary Dickkopf-related protein 3 as a novel biomarker for kidney function decline in children with Alport syndrome (2025) Boeckhaus J, Tönshoff B, Weber LT, Pape L, Latta K, Fehrenbach H, Lange-Sperandio B, et al. Journal article Tumor volume change at radiation boost planning to estimate the response to chemoradiotherapy in stage III unresectable NSCLC (TORCH): a multicenter retrospective observational study (2025) Trommer S, Müller JA, Oertel M, Ehret F, Roohani S, Ha HM, Ha QN, et al. Journal article Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. (2025) Forschner A, Kähler KC, Gschnell M, Langan EA, Weishaupt C, Meiss F, Thoms KM, et al. Journal article